skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration
Executive Summary

According to the National Institutes of Health, 126.1 million adults in the U.S. (or 40.1% of the population) report experiencing some pain in the previous 3 months, with 25.3 million (or 8.1%) suffering from chronic pain and 23.4 million (or 7.4%) reporting high pain levels (Nahin, 2015). According to the American Pain Society, the direct and indirect costs of pain in the U.S. total between $560 billion and $635 billion, with direct healthcare costs accounting for 47% and indirect costs such as lost worker productivity accounting for the remaining 53%. Pain-related costs exceed those of heart disease ($309 billion), cancer ($243 billion), and diabetes ($188 billion) (Gaskin, 2012).

U.S. Markets Approaches to Pain Managment

Multidisciplinary pain management plans may involve the use of pharmacologic, device-based, or alternative therapies; a combination of these modalities often is required to achieve optimal pain relief, particularly for those suffering from chronic pain. A major trend driving the innovation and development of improved pain management treatments in the pain management industry is the demographics of the aging United States (U.S.) population.
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management Meddevicetracker.
View full report here

Read also

  • Medtech Insight: global medical technology news & analysis

    Pre-MDR Predictions and What You Can Expect

    Updates to the EU Medical Devices Regulation are just weeks away from becoming a reality for manufacturers and suppliers. Medtech Insight delivers expert insights into the latest developments and what they could mean for your business.

    Topics Medtech

    Single Report

  • Medtech Insight: global medical technology news & analysis

    Medtech Deal-Making Round Up

    Keep current with comprehensive coverage of today’s deals and their impact on the future of the medtech landscape. Medtech Insight brings you insight and analysis of significant recent deals and what they mean for your strategy. Stay in the know with your free Quarterly Roundup.

    Topics Medtech

    Single Report

  • Medtech Insight: global medical technology news & analysis

    US Administrations and Medtech Industry: An International Focus

    As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the US medtech market can we expect to see over the next four years?

    Topics Medtech

    Single Report
;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now